GMP CSV services
Mastering Compliance , Ensuring Integrity and Efficiency through Reliable CSV Solutions
We ensure that every detail is thoroughly verified and meets all requirements with our Computer System Validation Services
We validate by examination and provision of objective evidence that software parameters align with user needs and intended uses, and that specific requirements implemented through software can be consistently fulfilled.
At Zenovel, we uses the GAMP 5 “V-Model” to ensure the safety, accuracy, and quality of computerized systems used in GxP activities, including production, raw material receipt, storage, dispensing, exporting, and quality control. This risk-based methodology includes IT infrastructure verification, routine reviews, system shutdown, planning, specifications, setup, verification, and reporting.
Our Key Expert Services Involves
We are able to assist you in the following areas of services:
- Computer Systems Validation for Manufacturing / Laboratory Instruments: It ensures the validation of instruments such as PLC, SCADA, BMS, MES,LIMS , ERP, EBMR-EBPR, DMS-LMS
- CSV for Excel Validation and Clinical Research Software
- Data Integrity Audit and GAP Analysis: Ensuring 21 CFR Part 11 and Annex 11 compliance, third party vendor audit, FAT- SAT for equipment
- Remediation for CSV- DATA Integrity related issues.
- Fool proof System owner validation tasks: Services like data integrity, backup – restoration, archival- retrieval data retention and migration check.
- Compliance Training: Covering topics such as importance of validation, the role of FDA, 21 CFR part 11 compliance, Annex- 11, ALCOA+, GAMP5, risk assessment, CSV deliverables, data integrity, and insights from recent and historical 483- warning letters
Why Choose Zenovel for GMP CSV Services?
- Cost Reduction and Time Efficiency
- Dedicated to Adherence
We apply audit trials and clear, unambiguous documentation to demonstrate compliance with Annex 11, and 21 CFR Part 11.
- Assurance
Our procedure prioritizes data integrity, accuracy, dependability, and consistency, ensuring clients receive reliable and trustworthy results.
- Flexible delivery model
We offer customized delivery options through the use of offshore, remote, and onsite resources.
People Also Ask (FAQs)
GMP Computer System Validation (CSV) is a documented process used in pharmaceutical computer system validation to ensure that computerized systems consistently perform as intended and comply with GMP regulations and data integrity requirements. Through professional GMP CSV services, companies validate systems used in manufacturing, laboratories, and quality management to ensure accuracy, reliability, and compliance throughout the system lifecycle.
Computerized System Validation under GMP is required by global regulatory authorities such as the US FDA and EMA to protect product quality and patient safety. Zenovel supports organizations by delivering GMP-compliant CSV services aligned with 21 CFR Part 11 and EU Annex 11 requirements. With a focus on data integrity and regulatory compliance, Zenovel ensures that electronic records and computerized systems meet global standards and are fully audit-ready.
Effective GMP Computerized System Validation services require comprehensive documentation. Key documents include the Validation Master Plan (VMP), User Requirement Specification (URS), Risk Assessment, Functional Specification (FS), Design Specification (DS), Installation Qualification (IQ), Operational Qualification (OQ), Performance Qualification (PQ), and a Validation Summary Report (VSR). These documents ensure regulatory compliance, audit readiness, and successful GMP inspections.
Under GMP regulations, any computerized system that impacts product quality, patient safety, or GMP data integrity must undergo validation. This includes systems such as ERP, LIMS, QMS software, Manufacturing Execution Systems (MES), laboratory instruments with software, and cloud-based quality systems. Zenovel supports validation of these systems through comprehensive GMP Computerized System Validation (CSV) services, ensuring they are compliant, secure, and aligned with global regulatory expectations.
The GAMP 5 risk-based approach is widely used in GMP Computerized System Validation services. Developed by the International Society for Pharmaceutical Engineering (ISPE), this approach focuses validation efforts on systems with the highest impact on product quality, patient safety, and regulatory compliance. By applying risk-based CSV validation, companies can streamline documentation while maintaining strong compliance with GMP data integrity standards.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
